Literature DB >> 8532623

Prenatal diagnosis of Charcot-Marie-Tooth disease type 1A (CMT1A) using molecular genetic techniques.

R Navon1, V Timmerman, A Löfgren, P Liang, E Nelis, M Zeitune, C Van Broeckhoven.   

Abstract

Charcot-Marie-Tooth disease type 1A (CMT1A) is a frequent hereditary motor and sensory neuropathy of the peripheral nerves. In most cases, the disease is associated with a 1.5 Mb tandem duplication at 17p11.2. A 42-year-old pregnant women requested prenatal diagnosis because of her age and since both her husband and two children were severely affected with CMT1. The CMT1A duplication was demonstrated in the father's, the two children's, and the fetus's DNA using different molecular genetic methods. Although cytogenetical analysis showed a normal female karyotype in the fetus, the parents decided to terminate the pregnancy because of the genetic risk associated with the CMT1A duplication.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8532623     DOI: 10.1002/pd.1970150708

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  8 in total

1.  Diagnosis of the CMT1A duplication by PCR based detection of a novel junction fragment.

Authors:  O Combarros; A Oterino; J Berciano; A Benito; J L Fernández-Luna
Journal:  J Med Genet       Date:  1998-11       Impact factor: 6.318

2.  Detection of the CMT1A/HNPP recombination hotspot in unrelated patients of European descent.

Authors:  V Timmerman; B Rautenstrauss; L T Reiter; T Koeuth; A Löfgren; T Liehr; E Nelis; K D Bathke; P De Jonghe; H Grehl; J J Martin; J R Lupski; C Van Broeckhoven
Journal:  J Med Genet       Date:  1997-01       Impact factor: 6.318

3.  A comparison of methods for gene dosage analysis in HMSN type 1.

Authors:  J S Rowland; D E Barton; G R Taylor
Journal:  J Med Genet       Date:  2001-02       Impact factor: 6.318

Review 4.  Inherited focal, episodic neuropathies: hereditary neuropathy with liability to pressure palsies and hereditary neuralgic amyotrophy.

Authors:  Phillip F Chance
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

5.  Effectiveness of real-time quantitative PCR compare to repeat PCR for the diagnosis of Charcot-Marie-Tooth Type 1A and hereditary neuropathy with liability to pressure palsies.

Authors:  Jong Rak Choi; Woon Hyoung Lee; Il Nam Sunwoo; Eun Kyung Lee; Chang Hoon Lee; Jong Baeck Lim
Journal:  Yonsei Med J       Date:  2005-06-30       Impact factor: 2.759

6.  A rapid and reliable detection system for the analysis of PMP22 gene dosage by MP/DHPLC assay.

Authors:  Chia-Yun Lin; Yi-Ning Su; Chien-Nan Lee; Chia-Cheng Hung; Wen-Fang Cheng; Win-Li Lin; Chi-An Chen; Sung-Tsang Hsieh
Journal:  J Hum Genet       Date:  2006-02-04       Impact factor: 3.172

7.  Mutation analysis of the nerve specific promoter of the peripheral myelin protein 22 gene in CMT1 disease and HNPP.

Authors:  E Nelis; P De Jonghe; E De Vriendt; P I Patel; J J Martin; C Van Broeckhoven
Journal:  J Med Genet       Date:  1998-07       Impact factor: 6.318

8.  Well-devised quantification analysis for duplication mutation of Duchenne muscular dystrophy aimed at preimplantation genetic diagnosis.

Authors:  Akira Nakabayashi; Kou Sueoka; Hiroto Tajima; Kenji Sato; Yoshiaki Sakamoto; Shingo Katou; Yasunori Yoshimura
Journal:  J Assist Reprod Genet       Date:  2007-03-06       Impact factor: 3.412

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.